Form 4: Jazz Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals, sold 1,905 ordinary shares to cover tax obligations arising from vesting restricted stock units.

Summary

• On March 5, 2025, Samantha Pearce, the EVP and Chief Commercial Officer of Jazz Pharmaceuticals, sold 1,905 ordinary shares of the company.
• The shares were sold at a price of $138.95 per share.
• The sale was conducted to satisfy tax obligations related to the vesting of previously granted restricted stock units.
• Following the transaction, Pearce directly owns 41,226 ordinary shares of Jazz Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate positive or negative sentiment towards the company's prospects.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale.

Key Dates